| Event chart ASTELLAS PHARMA INC. |
|
|
|
| Upcoming events on ASTELLAS PHARMA INC. |
|
| 09/29/21 | | Ex-dividend day for interim dividend |
| 11/04/21 | | Interim 2021 Earnings Release (Projected) |
| 02/03/22 | | Q3 2021 Earnings Release (Projected) |
| 04/28/22 | | FY 2021 Earnings Release (Projected) |
| 07/29/22 | | Q1 2023 Earnings Release (Projected) |
|
| Past events on ASTELLAS PHARMA INC. |
|
| 09/26/21 | 08:30pm | | SKYLIGHT 2 Study Update Call |
| 07/30/21 | 03:00am | | Q1 2021 Earnings Call |
| 07/30/21 | | Q1 2021 Earnings Release |
| 06/17/21 | 09:00pm | | Annual General Meeting |
| 06/11/21 | 03:00am | | European Hematology Association Congress - Abstract #EP448 |
| 06/11/21 | 03:00am | | European Hematology Association Congress - Abstract #EP441 |
| 06/11/21 | 03:00am | | European Hematology Association Congress - Abstract #S135 |
| 06/11/21 | 03:00am | | European Hematology Association Congress - Abstract #EP438 |
| 06/11/21 | 03:00am | | European Hematology Association Congress - Abstract #EP437 |
| 06/11/21 | 03:00am | | European hematology association congress - abstract: s313 |
|
| Past dividends on ASTELLAS PHARMA INC. |
|
| 03/30/21 | | Final Payment 21 JPY |
| 09/29/20 | | Interim Payment 21 JPY |
| 03/30/20 | | Final Payment 20 JPY |
| 09/27/19 | | Interim Payment 20 JPY |
| 03/27/19 | | Final Payment 19 JPY |
| 09/26/18 | | Interim Payment 19 JPY |
| 03/28/18 | | Final Payment 18 JPY |
| 09/27/17 | | Interim Payment 18 JPY |
| 03/29/17 | | Final Payment 17 JPY |
| 09/28/16 | | Interim Payment 17 JPY |
|
|
|
| Fiscal Period : March | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
Sales
M JPY |
Released
Forecast
Spread | 1 311 665
1 319 255
-0,58% | 1 300 316
1 295 193
0,40% | 1 306 348
1 300 930
0,42% | 1 300 843
1 274 827
2,0% | 1 249 528
1 258 841
-0,74% |
1 324 942
|
Operating income
(EBITDA)
M JPY |
Released
Forecast
Spread | 324 621
331 297
-2,0% | 278 121
287 331
-3,2% | 307 370
320 763
-4,2% | 310 387
316 993
-2,1% | 208 703
300 597
-31% |
329 166
|
Operating profit
(EBIT)
M JPY |
Released
Forecast
Spread | 260 830
271 929
-4,1% | 213 258
228 416
-6,6% | 243 912
261 093
-6,6% | 243 991
257 148
-5,1% | 136 051
221 342
-39% |
248 638
|
Pre-Tax Profit
(EBT)
M JPY |
Released
Forecast
Spread | 281 769
278 738
1,1% | 218 113
230 652
-5,4% | 248 967
259 605
-4,1% | 245 350
262 926
-6,7% | 145 324
219 749
-34% |
244 747
|
Net income
M JPY |
Released
Forecast
Spread | 218 701
205 634
6,4% | 164 679
178 600
-7,8% | 222 265
215 115
3,3% | 195 411
203 519
-4,0% | 120 589
176 431
-32% |
194 476
|
EPS
JPY |
Released
Forecast
Spread | 104
97,9
5,9% | 81,1
89,5
-9,4% | 115
113
1,6% | 104
113
-7,8% | 64,9
96,5
-33% |
106
| | Announcement Date | 04/27/2017 | 04/26/2018 | 04/25/2019 | 05/14/2020 | 04/27/2021 | - |
|
|
|
| Fiscal Period : March | 2017 S1 | 2018 S1 | 2018 S2 | 2019 S1 | 2019 Q4 | 2019 S2 | 2020 Q1 | 2020 Q2 | 2020 S1 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 S1 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2022 S1 | 2023 Q1 | 2023 S1 |
Sales
M JPY |
Released
Forecast
Spread | 651 673
655 500
-0,58% | 639 754
633 500
0,99% | 660 562
653 200
1,1% | 647 096
646 500
0,09% | 301 320
311 288
-3,2% |
| 334 134
313 367
6,6% | 316 336
300 622
5,2% | 650 470
630 717
3,1% | 338 065
327 167
3,3% | 312 308
293 033
6,6% | 306 969
313 838
-2,2% | 308 511
317 330
-2,8% | 615 480
631 150
-2,5% | 325 427
322 842
0,80% | 308 621
315 922
-2,3% | 326 143
317 725
2,6% |
327 786
|
348 300
|
341 533
|
653 900
|
323 800
|
684 000
|
Operating income
(EBITDA)
M |
Released
Forecast
Spread | 198 738
| 128 290
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating profit
(EBIT)
M JPY |
Released
Forecast
Spread | 157 057
163 000
-3,6% | 96 077
112 000
-14% | 117 181
109 250
7,3% | 126 842
131 500
-3,5% | 34 541
54 839
-37% |
| 77 086
67 500
14% | 85 110
60 293
41% | 162 196
135 036
20% | 75 462
64 475
17% | 6 333
35 700
-82% | 60 815
72 233
-16% | 26 057
69 070
-62% | 86 872
139 408
-38% | 72 598
67 332
7,8% | -23 419
55 665
-142% | 36 090
57 475
-37% |
68 403
|
72 633
|
63 633
|
138 200
|
65 900
|
160 500
|
Pre-Tax Profit
(EBT)
M JPY |
Released
Forecast
Spread | 157 772
164 500
-4,1% | 101 224
119 400
-15% | 116 889
109 300
6,9% | 128 298
| 36 139
55 100
-34% |
| 76 528
68 000
13% | 85 056
60 593
40% | 161 584
134 807
20% | 77 601
64 575
20% | 6 165
39 200
-84% | 60 238
72 033
-16% | 28 853
69 236
-58% | 89 091
139 808
-36% | 75 136
67 337
12% | -18 903
57 000
-133% | 35 830
66 200
-46% |
75 500
|
73 500
|
49 600
|
143 200
|
74 400
|
161 500
|
Net income
M JPY |
Released
Forecast
Spread | 115 064
120 900
-4,8% | 82 117
92 400
-11% | 82 562
80 100
3,1% | 103 867
106 000
-2,0% | 30 730
43 529
-29% |
| 58 518
53 533
9,3% | 70 009
47 593
47% | 128 527
105 652
22% | 61 494
52 900
16% | 5 390
30 600
-82% | 50 413
56 367
-11% | 22 425
54 652
-59% | 72 838
110 808
-34% | 60 079
53 195
13% | -12 328
44 500
-128% | 30 687
52 250
-41% |
58 900
|
57 300
|
38 700
|
113 700
|
60 600
|
128 000
|
EPS
|
Released
Forecast
Spread | 54,2
57,9
-6,5% | 40,0
45,8
-13% | 41,1
38,4
7,1% | 53,2
51,1
4,1% | 16,4
22,7
-28% | 61,9
| 31,0
27,2
14% | 37,1
29,7
25% | 68,2
57,4
19% | 32,8
29,3
12% | 3,19
15,6
-80% | 27,1
29,3
-7,4% | 12,1
27,3
-56% | 39,2
54,5
-28% | 32,4
30,1
7,4% | -6,63
23,0
-129% | 16,6
23,9
-31% |
28,5
|
32,6
|
24,6
|
61,4
|
28,7
|
69,1
| | Announcement Date | 10/28/2016 | 10/31/2017 | 04/26/2018 | 10/31/2018 | 04/25/2019 | 04/25/2019 | 07/30/2019 | 10/31/2019 | 10/31/2019 | 01/31/2020 | 05/14/2020 | 08/04/2020 | 10/30/2020 | 10/30/2020 | 01/29/2021 | 04/27/2021 | 07/30/2021 | - | - | - | - | - | - | |
|
|
| Upcoming sector events for ASTELLAS PHARMA INC. |
|
| |
|
| Past sector events for ASTELLAS PHARMA INC. |
|
| |
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
Previous year